Drug Eluting Balloon
B. Braun Vascular Systems presents a Drug Eluting Balloon for PTCA, based on a polymer-free carrier matrix. This most innovative product is the result of our sustained research for new options and improvements in the field of coronary angioplasty. Clinically proven, it offers completely new procedural options to treat vascular stenoses since the drug elution does not require a stent platform.
Patient Information
“Coronary artery disease and treatment options”
Within the following sites we would like to answer some of your questions on coronary artery disease (CAD), the diagnostic procedure and state of the art treatment options. more
B. Braun – April 2012
First Patient Enrolled in Landmark Clinical Trial – Basket-Small 2
Dr. Raban Jeger from the University Hospital in Basel enrolled the first patient in the BASKET-SMALL 2 trial. The purpose of this clinical trial is comparing two different treatment options for lesions in small coronary arteries. This landmark study is the first randomized clinical trial for the Drug-Eluting Balloons (DEB) with a clinical endpoint. more as PDF Download
